"10.1371_journal.pone.0077163","plos one","2013-10-08T00:00:00Z","Signe Modvig; Matilda Degn; Henrik Horwitz; Stig P Cramer; Henrik B W Larsson; Benedikte Wanscher; Finn Sellebjerg; Jette L Frederiksen","MS Clinic, Department of Neurology, Copenhagen University Hospital Glostrup, Glostrup, Denmark; Functional Imaging Unit, Department of Diagnostics, Copenhagen University Hospital, Glostrup, Glostrup, Denmark; Department of Clinical Neurophysiology, Copenhagen University Hospital Glostrup, Glostrup, Denmark; Danish MS Research Centre, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark","Conceived and designed the experiments: SM FS MD JF. Contributed reagents/materials/analysis tools: JF FS. Wrote the manuscript: SM. Clinical examinations, MRI and neurophysiology: SM HH JF HL SC BW. Biomarker analysis: SM MD. Statistical analysis: SM HH. Interpretation of data: SM MD FS JF. Critical revision MD HH SC HL BW FS JF.","Signe Modvig has received support for congress participation from Allergan. Matilda Degn has received unrestricted research funding from Biogen idec Henrik Horwitz has nothing to disclose Stig Præstekjær Cramer has received commercial research support from Biogen Idec, received honoraria from Biogen Idec for speaking engagements and funding for travel from Merck Serono. Dr. Cramer has received non-profit foundation research support from The Danish Multiple Sclerosis Society, and government research support from The Research Foundation of the Capital Region of Denmark, Foundation for Health Research. Henrik BW Larsson has nothing to disclose Benedikte Wanscher has nothing to disclose Finn T Sellebjerg has served on scientific advisory boards for Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis and TEVA, has been on the steering committee of a clinical trial sponsored by Merck Serono, and served as consultant for Biogen Idec and Novo Nordisk; has received support for congress participation from Biogen Idec, Novartis and Sanofi Aventis; has received speaker honoraria from Biogen Idec, Merck Serono, Bayer Schering, Schering-Plough, Sanofiaventis and Novartis. His laboratory has received research support from Biogen Idec, Bayer Schering, Merck Serono, Sanofi-Aventis and Novartis. Jette Lautrup Frederiksen has served on scientific advisory boards for and received funding for travel related to these activities as well as honoraria from Biogen Idec, Merck Serono, Sanofi-Aventis, Teva, Novartis and Almirall. Jette Frederiksen has received speaker honoraria from Biogen Idec, Merck Serono and Teva. She has served as advisor on preclinical development for Takeda. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","10","Signe Modvig","SM",8,TRUE,4,NA,NA,1,TRUE,FALSE,FALSE,0,NA,FALSE
